National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 7786 [06-1338]
Download as PDF
<![CDATA[
7786
Federal Register / Vol. 71, No. 30 / Tuesday, February 14, 2006 / Notices
Research; 93.849, Kidney Diseeases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: February 2, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–1332 Filed 2–13–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
rmajette on PROD1PC67 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, ZAl1–SR–A–M3—Unit for
HIV/AIDS Clinical Trials Network (4).
Date: February 27, 2006.
Time: 9 a.m. to 4 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Room 3200, Bethesda, MD 20817. (Telephone
Conference Call).
Contact Person: Stefani T. Rudnick, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616. 301–496–2550.
srudnick@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, ZAl1–TP–A–M2—Unit for
HIV/AIDS Clinical Trials Network (7).
Date: February 27, 2006.
Time: 10 a.m. to 4 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Room 3200, Bethesda, MD 20817. (Telephone
Conference Call).
Contact Person: Thames E. Pickett, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
VerDate Aug<31>2005
14:46 Feb 13, 2006
Jkt 208001
Activities, NIH/NIAID/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616. 301–496–2550.
pickette@niaid,nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, ZAl1–MP–I–M1—RFA–AI–
05–026—Cooperative Study Group for
Autoimmune Disease Prevention.
Date: February 28–March 1, 2006.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Mercy R. PrabhuDas, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616. 301–451–2615.
mp457n@nih.gov
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 2, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–1337 Filed 2–13–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections 552(b)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: national Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Units for HIV/AIDS Clinical
Trials Network (11)–ZAI1–BLG–A–M2.
Date: February 28, 2006.
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817. (Telephone Conference
Call).
Contact Person: Brenda Lange-Gustafson,
PhD, Scientific Review Administrator,
NIAID, DEA, Scientific Review Program,
Room 2217, 6700–B Rockledge Drive, MSC–
7616, Bethesda, MD 20892–7616. (301) 496–
2550. bgustafson@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: February 2, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–1338 Filed 2–13–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group, Molecular
and Cellular Endocrinology Study Section.
Date: February 13–14, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Syed M. Amir, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6172,
MSC 7892, Bethesda, MD 20892. (301) 435–
1043. amirs@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
E:\FR\FM\14FEN1.SGM
14FEN1
]]>Agencies
[Federal Register Volume 71, Number 30 (Tuesday, February 14, 2006)]
[Notices]
[Page 7786]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-1338]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552(b)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: national Institute of Allergy and Infectious
Diseases Special Emphasis Panel, Units for HIV/AIDS Clinical Trials
Network (11)-ZAI1-BLG-A-M2.
Date: February 28, 2006.
Time: 11 a.m. to 6 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: National Institutes of Health, Rockledge 6700, 6700B
Rockledge Drive, Bethesda, MD 20817. (Telephone Conference Call).
Contact Person: Brenda Lange-Gustafson, PhD, Scientific Review
Administrator, NIAID, DEA, Scientific Review Program, Room 2217,
6700-B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616. (301)
496-2550. bgustafson@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: February 2, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-1338 Filed 2-13-06; 8:45 am]
BILLING CODE 4140-01-M
